Idiopathic Thrombocytopenic Purpura Therapeutics Market Expand at a CAGR of 5.9% From 2014 to 2020 | Grand View Research Inc.
San Francisco, United States, 2019-Nov-05 — /EPR Network/ — Global idiopathic thrombocytopenic purpura (ITP) therapeutics market is expected to reach USD 566.4 million by 2020. Rising [read full press release…]